Long-acting Reversible Contraceptives (LARCs) Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Long-acting Reversible Contraceptives (LARCs) in global, including the following market information:
Global Long-acting Reversible Contraceptives (LARCs) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Long-acting Reversible Contraceptives (LARCs) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Long-acting Reversible Contraceptives (LARCs) companies in 2021 (%)
The global Long-acting Reversible Contraceptives (LARCs) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hormonal Intrauterine Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Long-acting Reversible Contraceptives (LARCs) include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna and ASPIVIX, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Long-acting Reversible Contraceptives (LARCs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Long-acting Reversible Contraceptives (LARCs) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Long-acting Reversible Contraceptives (LARCs) Market Segment Percentages, by Type, 2021 (%)
Global Long-acting Reversible Contraceptives (LARCs) Market Segment Percentages, by Application, 2021 (%)
Global Long-acting Reversible Contraceptives (LARCs) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Long-acting Reversible Contraceptives (LARCs) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Long-acting Reversible Contraceptives (LARCs) revenues share in global market, 2021 (%)
Key companies Long-acting Reversible Contraceptives (LARCs) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Long-acting Reversible Contraceptives (LARCs) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Long-acting Reversible Contraceptives (LARCs) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Long-acting Reversible Contraceptives (LARCs) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Long-acting Reversible Contraceptives (LARCs) companies in 2021 (%)
The global Long-acting Reversible Contraceptives (LARCs) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hormonal Intrauterine Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Long-acting Reversible Contraceptives (LARCs) include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna and ASPIVIX, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Long-acting Reversible Contraceptives (LARCs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Long-acting Reversible Contraceptives (LARCs) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Long-acting Reversible Contraceptives (LARCs) Market Segment Percentages, by Type, 2021 (%)
- Hormonal Intrauterine Devices
- Copper Intrauterine Devices
- Contraceptive Implants
- Others
Global Long-acting Reversible Contraceptives (LARCs) Market Segment Percentages, by Application, 2021 (%)
- Age 20-24
- Age 25-34
- Age 35-44
- Others
Global Long-acting Reversible Contraceptives (LARCs) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Long-acting Reversible Contraceptives (LARCs) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Long-acting Reversible Contraceptives (LARCs) revenues share in global market, 2021 (%)
Key companies Long-acting Reversible Contraceptives (LARCs) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Long-acting Reversible Contraceptives (LARCs) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer
- Merck
- Cooper Companies
- AbbVie Allergan
- Yantai JiShengYaoXie
- H & J Medical
- HRA Pharma
- Pregna
- ASPIVIX
- Shanghai Dahua Pharmaceuticals
- Williams Medical Supplies
- Laboratoire 7 MED
- Durbin
- Laboratoire CCD
- Prosan
- OCON
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Long-acting Reversible Contraceptives (LARCs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Long-acting Reversible Contraceptives (LARCs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) OVERALL MARKET SIZE
2.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size: 2021 VS 2028
2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Long-acting Reversible Contraceptives (LARCs) Players in Global Market
3.2 Top Global Long-acting Reversible Contraceptives (LARCs) Companies Ranked by Revenue
3.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Companies
3.4 Global Long-acting Reversible Contraceptives (LARCs) Sales by Companies
3.5 Global Long-acting Reversible Contraceptives (LARCs) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Long-acting Reversible Contraceptives (LARCs) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Long-acting Reversible Contraceptives (LARCs) Players in Global Market
3.8.1 List of Global Tier 1 Long-acting Reversible Contraceptives (LARCs) Companies
3.8.2 List of Global Tier 2 and Tier 3 Long-acting Reversible Contraceptives (LARCs) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Long-acting Reversible Contraceptives (LARCs) Market Size Markets, 2021 & 2028
4.1.2 Hormonal Intrauterine Devices
4.1.3 Copper Intrauterine Devices
4.1.4 Contraceptive Implants
4.1.5 Others
4.2 By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue & Forecasts
4.2.1 By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2022
4.2.2 By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2023-2028
4.2.3 By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
4.3 By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales & Forecasts
4.3.1 By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2022
4.3.2 By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2023-2028
4.3.3 By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
4.4 By Type - Global Long-acting Reversible Contraceptives (LARCs) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Long-acting Reversible Contraceptives (LARCs) Market Size, 2021 & 2028
5.1.2 Age 20-24
5.1.3 Age 25-34
5.1.4 Age 35-44
5.1.5 Others
5.2 By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue & Forecasts
5.2.1 By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2022
5.2.2 By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2023-2028
5.2.3 By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
5.3 By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales & Forecasts
5.3.1 By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2022
5.3.2 By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2023-2028
5.3.3 By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
5.4 By Application - Global Long-acting Reversible Contraceptives (LARCs) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Long-acting Reversible Contraceptives (LARCs) Market Size, 2021 & 2028
6.2 By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue & Forecasts
6.2.1 By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2022
6.2.2 By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2023-2028
6.2.3 By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
6.3 By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales & Forecasts
6.3.1 By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2022
6.3.2 By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2023-2028
6.3.3 By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028
6.4.2 By Country - North America Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2028
6.4.3 US Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.4.4 Canada Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.4.5 Mexico Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028
6.5.2 By Country - Europe Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2028
6.5.3 Germany Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.4 France Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.5 U.K. Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.6 Italy Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.7 Russia Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.8 Nordic Countries Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.9 Benelux Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028
6.6.2 By Region - Asia Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2028
6.6.3 China Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.6.4 Japan Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.6.5 South Korea Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.6.6 Southeast Asia Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.6.7 India Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028
6.7.2 By Country - South America Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2028
6.7.3 Brazil Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.7.4 Argentina Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2028
6.8.3 Turkey Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.8.4 Israel Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.8.5 Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.8.6 UAE Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.1.4 Bayer Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.2.4 Merck Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Cooper Companies
7.3.1 Cooper Companies Corporate Summary
7.3.2 Cooper Companies Business Overview
7.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.3.5 Cooper Companies Key News
7.4 AbbVie Allergan
7.4.1 AbbVie Allergan Corporate Summary
7.4.2 AbbVie Allergan Business Overview
7.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.4.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.4.5 AbbVie Allergan Key News
7.5 Yantai JiShengYaoXie
7.5.1 Yantai JiShengYaoXie Corporate Summary
7.5.2 Yantai JiShengYaoXie Business Overview
7.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.5.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.5.5 Yantai JiShengYaoXie Key News
7.6 H & J Medical
7.6.1 H & J Medical Corporate Summary
7.6.2 H & J Medical Business Overview
7.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.6.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.6.5 H & J Medical Key News
7.7 HRA Pharma
7.7.1 HRA Pharma Corporate Summary
7.7.2 HRA Pharma Business Overview
7.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.7.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.7.5 HRA Pharma Key News
7.8 Pregna
7.8.1 Pregna Corporate Summary
7.8.2 Pregna Business Overview
7.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.8.4 Pregna Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.8.5 Pregna Key News
7.9 ASPIVIX
7.9.1 ASPIVIX Corporate Summary
7.9.2 ASPIVIX Business Overview
7.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.9.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.9.5 ASPIVIX Key News
7.10 Shanghai Dahua Pharmaceuticals
7.10.1 Shanghai Dahua Pharmaceuticals Corporate Summary
7.10.2 Shanghai Dahua Pharmaceuticals Business Overview
7.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.10.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.10.5 Shanghai Dahua Pharmaceuticals Key News
7.11 Williams Medical Supplies
7.11.1 Williams Medical Supplies Corporate Summary
7.11.2 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Business Overview
7.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.11.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.11.5 Williams Medical Supplies Key News
7.12 Laboratoire 7 MED
7.12.1 Laboratoire 7 MED Corporate Summary
7.12.2 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Business Overview
7.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.12.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.12.5 Laboratoire 7 MED Key News
7.13 Durbin
7.13.1 Durbin Corporate Summary
7.13.2 Durbin Long-acting Reversible Contraceptives (LARCs) Business Overview
7.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.13.4 Durbin Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.13.5 Durbin Key News
7.14 Laboratoire CCD
7.14.1 Laboratoire CCD Corporate Summary
7.14.2 Laboratoire CCD Business Overview
7.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.14.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.14.5 Laboratoire CCD Key News
7.15 Prosan
7.15.1 Prosan Corporate Summary
7.15.2 Prosan Business Overview
7.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.15.4 Prosan Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.15.5 Prosan Key News
7.16 OCON
7.16.1 OCON Corporate Summary
7.16.2 OCON Business Overview
7.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.16.4 OCON Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.16.5 OCON Key News
8 GLOBAL LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Long-acting Reversible Contraceptives (LARCs) Production Capacity, 2017-2028
8.2 Long-acting Reversible Contraceptives (LARCs) Production Capacity of Key Manufacturers in Global Market
8.3 Global Long-acting Reversible Contraceptives (LARCs) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) SUPPLY CHAIN ANALYSIS
10.1 Long-acting Reversible Contraceptives (LARCs) Industry Value Chain
10.2 Long-acting Reversible Contraceptives (LARCs) Upstream Market
10.3 Long-acting Reversible Contraceptives (LARCs) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Long-acting Reversible Contraceptives (LARCs) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Long-acting Reversible Contraceptives (LARCs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Long-acting Reversible Contraceptives (LARCs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) OVERALL MARKET SIZE
2.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size: 2021 VS 2028
2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Long-acting Reversible Contraceptives (LARCs) Players in Global Market
3.2 Top Global Long-acting Reversible Contraceptives (LARCs) Companies Ranked by Revenue
3.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Companies
3.4 Global Long-acting Reversible Contraceptives (LARCs) Sales by Companies
3.5 Global Long-acting Reversible Contraceptives (LARCs) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Long-acting Reversible Contraceptives (LARCs) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Long-acting Reversible Contraceptives (LARCs) Players in Global Market
3.8.1 List of Global Tier 1 Long-acting Reversible Contraceptives (LARCs) Companies
3.8.2 List of Global Tier 2 and Tier 3 Long-acting Reversible Contraceptives (LARCs) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Long-acting Reversible Contraceptives (LARCs) Market Size Markets, 2021 & 2028
4.1.2 Hormonal Intrauterine Devices
4.1.3 Copper Intrauterine Devices
4.1.4 Contraceptive Implants
4.1.5 Others
4.2 By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue & Forecasts
4.2.1 By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2022
4.2.2 By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2023-2028
4.2.3 By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
4.3 By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales & Forecasts
4.3.1 By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2022
4.3.2 By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2023-2028
4.3.3 By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
4.4 By Type - Global Long-acting Reversible Contraceptives (LARCs) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Long-acting Reversible Contraceptives (LARCs) Market Size, 2021 & 2028
5.1.2 Age 20-24
5.1.3 Age 25-34
5.1.4 Age 35-44
5.1.5 Others
5.2 By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue & Forecasts
5.2.1 By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2022
5.2.2 By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2023-2028
5.2.3 By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
5.3 By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales & Forecasts
5.3.1 By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2022
5.3.2 By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2023-2028
5.3.3 By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
5.4 By Application - Global Long-acting Reversible Contraceptives (LARCs) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Long-acting Reversible Contraceptives (LARCs) Market Size, 2021 & 2028
6.2 By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue & Forecasts
6.2.1 By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2022
6.2.2 By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2023-2028
6.2.3 By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
6.3 By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales & Forecasts
6.3.1 By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2022
6.3.2 By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales, 2023-2028
6.3.3 By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028
6.4.2 By Country - North America Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2028
6.4.3 US Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.4.4 Canada Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.4.5 Mexico Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028
6.5.2 By Country - Europe Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2028
6.5.3 Germany Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.4 France Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.5 U.K. Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.6 Italy Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.7 Russia Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.8 Nordic Countries Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.5.9 Benelux Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028
6.6.2 By Region - Asia Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2028
6.6.3 China Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.6.4 Japan Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.6.5 South Korea Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.6.6 Southeast Asia Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.6.7 India Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028
6.7.2 By Country - South America Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2028
6.7.3 Brazil Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.7.4 Argentina Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales, 2017-2028
6.8.3 Turkey Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.8.4 Israel Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.8.5 Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
6.8.6 UAE Long-acting Reversible Contraceptives (LARCs) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.1.4 Bayer Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.2.4 Merck Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Cooper Companies
7.3.1 Cooper Companies Corporate Summary
7.3.2 Cooper Companies Business Overview
7.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.3.5 Cooper Companies Key News
7.4 AbbVie Allergan
7.4.1 AbbVie Allergan Corporate Summary
7.4.2 AbbVie Allergan Business Overview
7.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.4.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.4.5 AbbVie Allergan Key News
7.5 Yantai JiShengYaoXie
7.5.1 Yantai JiShengYaoXie Corporate Summary
7.5.2 Yantai JiShengYaoXie Business Overview
7.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.5.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.5.5 Yantai JiShengYaoXie Key News
7.6 H & J Medical
7.6.1 H & J Medical Corporate Summary
7.6.2 H & J Medical Business Overview
7.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.6.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.6.5 H & J Medical Key News
7.7 HRA Pharma
7.7.1 HRA Pharma Corporate Summary
7.7.2 HRA Pharma Business Overview
7.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.7.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.7.5 HRA Pharma Key News
7.8 Pregna
7.8.1 Pregna Corporate Summary
7.8.2 Pregna Business Overview
7.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.8.4 Pregna Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.8.5 Pregna Key News
7.9 ASPIVIX
7.9.1 ASPIVIX Corporate Summary
7.9.2 ASPIVIX Business Overview
7.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.9.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.9.5 ASPIVIX Key News
7.10 Shanghai Dahua Pharmaceuticals
7.10.1 Shanghai Dahua Pharmaceuticals Corporate Summary
7.10.2 Shanghai Dahua Pharmaceuticals Business Overview
7.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.10.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.10.5 Shanghai Dahua Pharmaceuticals Key News
7.11 Williams Medical Supplies
7.11.1 Williams Medical Supplies Corporate Summary
7.11.2 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Business Overview
7.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.11.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.11.5 Williams Medical Supplies Key News
7.12 Laboratoire 7 MED
7.12.1 Laboratoire 7 MED Corporate Summary
7.12.2 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Business Overview
7.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.12.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.12.5 Laboratoire 7 MED Key News
7.13 Durbin
7.13.1 Durbin Corporate Summary
7.13.2 Durbin Long-acting Reversible Contraceptives (LARCs) Business Overview
7.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.13.4 Durbin Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.13.5 Durbin Key News
7.14 Laboratoire CCD
7.14.1 Laboratoire CCD Corporate Summary
7.14.2 Laboratoire CCD Business Overview
7.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.14.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.14.5 Laboratoire CCD Key News
7.15 Prosan
7.15.1 Prosan Corporate Summary
7.15.2 Prosan Business Overview
7.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.15.4 Prosan Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.15.5 Prosan Key News
7.16 OCON
7.16.1 OCON Corporate Summary
7.16.2 OCON Business Overview
7.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Major Product Offerings
7.16.4 OCON Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in Global (2017-2022)
7.16.5 OCON Key News
8 GLOBAL LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Long-acting Reversible Contraceptives (LARCs) Production Capacity, 2017-2028
8.2 Long-acting Reversible Contraceptives (LARCs) Production Capacity of Key Manufacturers in Global Market
8.3 Global Long-acting Reversible Contraceptives (LARCs) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) SUPPLY CHAIN ANALYSIS
10.1 Long-acting Reversible Contraceptives (LARCs) Industry Value Chain
10.2 Long-acting Reversible Contraceptives (LARCs) Upstream Market
10.3 Long-acting Reversible Contraceptives (LARCs) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Long-acting Reversible Contraceptives (LARCs) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Long-acting Reversible Contraceptives (LARCs) in Global Market
Table 2. Top Long-acting Reversible Contraceptives (LARCs) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Companies, 2017-2022
Table 5. Global Long-acting Reversible Contraceptives (LARCs) Sales by Companies, (K Units), 2017-2022
Table 6. Global Long-acting Reversible Contraceptives (LARCs) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Type
Table 9. List of Global Tier 1 Long-acting Reversible Contraceptives (LARCs) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Long-acting Reversible Contraceptives (LARCs) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2017-2022
Table 15. By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2023-2028
Table 16. By Application – Global Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2017-2022
Table 20. By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2023-2028
Table 21. By Region – Global Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2017-2022
Table 25. By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2023-2028
Table 26. By Country - North America Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2017-2022
Table 29. By Country - North America Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2023-2028
Table 38. By Country - South America Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2017-2022
Table 41. By Country - South America Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2023-2028
Table 46. Bayer Corporate Summary
Table 47. Bayer Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 48. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 51. Merck Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Cooper Companies Corporate Summary
Table 53. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 54. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. AbbVie Allergan Corporate Summary
Table 56. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 57. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Yantai JiShengYaoXie Corporate Summary
Table 59. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 60. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. H & J Medical Corporate Summary
Table 62. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 63. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. HRA Pharma Corporate Summary
Table 65. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 66. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Pregna Corporate Summary
Table 68. Pregna Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 69. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. ASPIVIX Corporate Summary
Table 71. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 72. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Shanghai Dahua Pharmaceuticals Corporate Summary
Table 74. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 75. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Williams Medical Supplies Corporate Summary
Table 77. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 78. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Laboratoire 7 MED Corporate Summary
Table 80. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 81. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Durbin Corporate Summary
Table 83. Durbin Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 84. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Laboratoire CCD Corporate Summary
Table 86. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 87. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Prosan Corporate Summary
Table 89. Prosan Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 90. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. OCON Corporate Summary
Table 92. OCON Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 93. OCON Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Long-acting Reversible Contraceptives (LARCs) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 95. Global Long-acting Reversible Contraceptives (LARCs) Capacity Market Share of Key Manufacturers, 2020-2022
Table 96. Global Long-acting Reversible Contraceptives (LARCs) Production by Region, 2017-2022 (K Units)
Table 97. Global Long-acting Reversible Contraceptives (LARCs) Production by Region, 2023-2028 (K Units)
Table 98. Long-acting Reversible Contraceptives (LARCs) Market Opportunities & Trends in Global Market
Table 99. Long-acting Reversible Contraceptives (LARCs) Market Drivers in Global Market
Table 100. Long-acting Reversible Contraceptives (LARCs) Market Restraints in Global Market
Table 101. Long-acting Reversible Contraceptives (LARCs) Raw Materials
Table 102. Long-acting Reversible Contraceptives (LARCs) Raw Materials Suppliers in Global Market
Table 103. Typical Long-acting Reversible Contraceptives (LARCs) Downstream
Table 104. Long-acting Reversible Contraceptives (LARCs) Downstream Clients in Global Market
Table 105. Long-acting Reversible Contraceptives (LARCs) Distributors and Sales Agents in Global Market
Table 1. Key Players of Long-acting Reversible Contraceptives (LARCs) in Global Market
Table 2. Top Long-acting Reversible Contraceptives (LARCs) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Companies, 2017-2022
Table 5. Global Long-acting Reversible Contraceptives (LARCs) Sales by Companies, (K Units), 2017-2022
Table 6. Global Long-acting Reversible Contraceptives (LARCs) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Type
Table 9. List of Global Tier 1 Long-acting Reversible Contraceptives (LARCs) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Long-acting Reversible Contraceptives (LARCs) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2017-2022
Table 15. By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2023-2028
Table 16. By Application – Global Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2017-2022
Table 20. By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2023-2028
Table 21. By Region – Global Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2017-2022
Table 25. By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), 2023-2028
Table 26. By Country - North America Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2017-2022
Table 29. By Country - North America Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2023-2028
Table 38. By Country - South America Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2017-2022
Table 41. By Country - South America Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales, (K Units), 2023-2028
Table 46. Bayer Corporate Summary
Table 47. Bayer Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 48. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 51. Merck Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Cooper Companies Corporate Summary
Table 53. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 54. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. AbbVie Allergan Corporate Summary
Table 56. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 57. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Yantai JiShengYaoXie Corporate Summary
Table 59. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 60. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. H & J Medical Corporate Summary
Table 62. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 63. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. HRA Pharma Corporate Summary
Table 65. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 66. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Pregna Corporate Summary
Table 68. Pregna Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 69. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. ASPIVIX Corporate Summary
Table 71. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 72. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Shanghai Dahua Pharmaceuticals Corporate Summary
Table 74. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 75. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Williams Medical Supplies Corporate Summary
Table 77. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 78. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Laboratoire 7 MED Corporate Summary
Table 80. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 81. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Durbin Corporate Summary
Table 83. Durbin Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 84. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Laboratoire CCD Corporate Summary
Table 86. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 87. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Prosan Corporate Summary
Table 89. Prosan Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 90. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. OCON Corporate Summary
Table 92. OCON Long-acting Reversible Contraceptives (LARCs) Product Offerings
Table 93. OCON Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Long-acting Reversible Contraceptives (LARCs) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 95. Global Long-acting Reversible Contraceptives (LARCs) Capacity Market Share of Key Manufacturers, 2020-2022
Table 96. Global Long-acting Reversible Contraceptives (LARCs) Production by Region, 2017-2022 (K Units)
Table 97. Global Long-acting Reversible Contraceptives (LARCs) Production by Region, 2023-2028 (K Units)
Table 98. Long-acting Reversible Contraceptives (LARCs) Market Opportunities & Trends in Global Market
Table 99. Long-acting Reversible Contraceptives (LARCs) Market Drivers in Global Market
Table 100. Long-acting Reversible Contraceptives (LARCs) Market Restraints in Global Market
Table 101. Long-acting Reversible Contraceptives (LARCs) Raw Materials
Table 102. Long-acting Reversible Contraceptives (LARCs) Raw Materials Suppliers in Global Market
Table 103. Typical Long-acting Reversible Contraceptives (LARCs) Downstream
Table 104. Long-acting Reversible Contraceptives (LARCs) Downstream Clients in Global Market
Table 105. Long-acting Reversible Contraceptives (LARCs) Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Long-acting Reversible Contraceptives (LARCs) Segment by Type
Figure 2. Long-acting Reversible Contraceptives (LARCs) Segment by Application
Figure 3. Global Long-acting Reversible Contraceptives (LARCs) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Long-acting Reversible Contraceptives (LARCs) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028 (US$, Mn)
Figure 7. Long-acting Reversible Contraceptives (LARCs) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Long-acting Reversible Contraceptives (LARCs) Revenue in 2021
Figure 9. By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 10. By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Long-acting Reversible Contraceptives (LARCs) Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 13. By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Long-acting Reversible Contraceptives (LARCs) Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 16. By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 19. US Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 24. Germany Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 25. France Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 33. China Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 37. India Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 40. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 44. Turkey Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Long-acting Reversible Contraceptives (LARCs) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Long-acting Reversible Contraceptives (LARCs) by Region, 2021 VS 2028
Figure 50. Long-acting Reversible Contraceptives (LARCs) Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Long-acting Reversible Contraceptives (LARCs) Segment by Type
Figure 2. Long-acting Reversible Contraceptives (LARCs) Segment by Application
Figure 3. Global Long-acting Reversible Contraceptives (LARCs) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Long-acting Reversible Contraceptives (LARCs) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Long-acting Reversible Contraceptives (LARCs) Revenue, 2017-2028 (US$, Mn)
Figure 7. Long-acting Reversible Contraceptives (LARCs) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Long-acting Reversible Contraceptives (LARCs) Revenue in 2021
Figure 9. By Type - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 10. By Type - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Long-acting Reversible Contraceptives (LARCs) Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 13. By Application - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Long-acting Reversible Contraceptives (LARCs) Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 16. By Region - Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 19. US Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 24. Germany Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 25. France Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 33. China Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 37. India Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 40. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share, 2017-2028
Figure 44. Turkey Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Long-acting Reversible Contraceptives (LARCs) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Long-acting Reversible Contraceptives (LARCs) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Long-acting Reversible Contraceptives (LARCs) by Region, 2021 VS 2028
Figure 50. Long-acting Reversible Contraceptives (LARCs) Industry Value Chain
Figure 51. Marketing Channels
